HUP0300997A2 - A MIA-fehérje alkalmazása immunterápiában - Google Patents

A MIA-fehérje alkalmazása immunterápiában

Info

Publication number
HUP0300997A2
HUP0300997A2 HU0300997A HUP0300997A HUP0300997A2 HU P0300997 A2 HUP0300997 A2 HU P0300997A2 HU 0300997 A HU0300997 A HU 0300997A HU P0300997 A HUP0300997 A HU P0300997A HU P0300997 A2 HUP0300997 A2 HU P0300997A2
Authority
HU
Hungary
Prior art keywords
mia
protein
immunotherapy
subject
peptides
Prior art date
Application number
HU0300997A
Other languages
English (en)
Inventor
Robert Louis Hubert Nelissen
Gijbertus Franciscus Maria Verheijden
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of HUP0300997A2 publication Critical patent/HUP0300997A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány tárgyát a MIA-fehérje és specifikus származékainakalkalmazása képezi immunmodulátor-ágensként autoimmun betegségek,közelebbről gyulladásos megbetegedések, például reumatoid artritiszkezelésére. A találmány tárgyát képezik a találmány szerintalkalmazható specifikus MIA-peptidek is, valamint a találmány szerintipeptideket tartalmazó gyógyászati készítmények. Ó
HU0300997A 2000-03-23 2001-03-15 A MIA-fehérje alkalmazása immunterápiában HUP0300997A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201063 2000-03-23
PCT/EP2001/002991 WO2001070253A1 (en) 2000-03-23 2001-03-15 Use of mia in immunotherapy

Publications (1)

Publication Number Publication Date
HUP0300997A2 true HUP0300997A2 (hu) 2003-07-28

Family

ID=8171248

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300997A HUP0300997A2 (hu) 2000-03-23 2001-03-15 A MIA-fehérje alkalmazása immunterápiában

Country Status (19)

Country Link
US (1) US20030091583A1 (hu)
EP (1) EP1267907A1 (hu)
JP (1) JP2003527435A (hu)
KR (1) KR20020089404A (hu)
CN (1) CN1418105A (hu)
AR (1) AR027694A1 (hu)
AU (1) AU783170B2 (hu)
BR (1) BR0109455A (hu)
CA (1) CA2399028A1 (hu)
CZ (1) CZ20023187A3 (hu)
HU (1) HUP0300997A2 (hu)
IL (1) IL150679A0 (hu)
MX (1) MXPA02008889A (hu)
NO (1) NO20024458L (hu)
NZ (1) NZ520346A (hu)
PL (1) PL358132A1 (hu)
RU (1) RU2002128351A (hu)
SK (1) SK13692002A3 (hu)
WO (1) WO2001070253A1 (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040076965A1 (en) * 2002-10-16 2004-04-22 Bosserhoff Anja Katrin MIA-2 protein
US8026354B2 (en) * 2005-11-23 2011-09-27 Institut Pasteur Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
BRPI0706575B8 (pt) * 2006-01-13 2021-05-25 Univ Indiana Res & Tech Corp uso colágeno de tipo v ou um componente antigênico do mesmo, e, método para identificar um paciente em espera de transplante de pulmão para um risco aumentado de rejeição de tecido de órgão transplantado.
EP2307048A4 (en) * 2008-07-16 2012-02-29 Baylor Res Inst HIV VACCINE BASED ON TARGETING OF MAXIMIZED GAG AND NEF ON DENDRITIC CELLS
CN102869679B (zh) * 2010-04-27 2015-11-25 Scil技术股份有限公司 稳定的水性mia/cd-rap制剂
ITRM20110134A1 (it) * 2011-03-22 2012-09-23 Matteo Bordignon Inibitori di mia (attività inibitoria melanoma) per identificare, prevenire e curare la vitiligine
AU2013234815B2 (en) * 2012-03-23 2017-06-22 The University Of Queensland Immunomodulatory agent and uses therefor
ITRM20120339A1 (it) * 2012-07-16 2014-01-17 Matteo Bordignon Uso di mia (attività inibitoria melanoma) per il trattamento della iper-pigmentazione cutanea e per lo sbiancamento cosmetico della pelle
CN116327971A (zh) * 2023-03-02 2023-06-27 暨南大学附属第一医院（广州华侨医院） 一种靶向cd74+促炎型巨噬细胞的药物载体及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE185152T1 (de) * 1993-07-20 1999-10-15 Roche Diagnostics Gmbh Melanom-inhibierendes protein
EP0972022A2 (en) * 1997-01-21 2000-01-19 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
DE59810255D1 (de) * 1997-10-16 2004-01-08 Scil Technology Holding Gmbh Nachweis von Knorpelerkrankungen mit MIA

Also Published As

Publication number Publication date
KR20020089404A (ko) 2002-11-29
NZ520346A (en) 2004-07-30
US20030091583A1 (en) 2003-05-15
RU2002128351A (ru) 2004-03-27
AU783170B2 (en) 2005-09-29
BR0109455A (pt) 2003-06-03
AR027694A1 (es) 2003-04-09
MXPA02008889A (es) 2003-04-25
AU4247601A (en) 2001-10-03
PL358132A1 (en) 2004-08-09
JP2003527435A (ja) 2003-09-16
CN1418105A (zh) 2003-05-14
NO20024458D0 (no) 2002-09-18
WO2001070253A1 (en) 2001-09-27
CA2399028A1 (en) 2001-09-27
IL150679A0 (en) 2003-02-12
NO20024458L (no) 2002-09-18
CZ20023187A3 (cs) 2003-01-15
EP1267907A1 (en) 2003-01-02
WO2001070253A8 (en) 2003-03-20
SK13692002A3 (sk) 2003-02-04

Similar Documents

Publication Publication Date Title
HUP0101948A2 (hu) Il-2-szelektív agonisták és antagonisták
HUP0303996A2 (hu) Vakcinakészítmények
DK0935607T3 (da) Oplöselige monovalente og multivalente MHC klasse II-fusionsproteiner samt anvendelser deraf
HUP0402162A2 (hu) A humán angiopoietin-2 specifikus kötőanyagai
HUP0302965A2 (hu) Vakcina
HUP0401124A2 (hu) VII koagulációs faktor származékok
NO20061736L (no) Krystallform av epotilon B
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
HUP0303753A2 (hu) Fúziós fehérjék immunogenitásának csökkentése
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
HUP0302585A2 (hu) Egy egyén allergiás reakcióra való hajlamának csökkentésére képes tejsavbaktériumok
HUP0301349A2 (hu) IL-11-tartalmú készítmények
HUP0300997A2 (hu) A MIA-fehérje alkalmazása immunterápiában
HUP0102142A2 (hu) Ciklosporinok alkalmazása gyulladással járó autoimmun betegségek kezelésében
HUP0302481A2 (hu) Virulencia gének, fehérjék és alkalmazásuk
PT1290160E (pt) Polipeptideos pellino humanos
AU2002251533A1 (en) Protein involved in restoration of cytoplasmic male sterility to fertility and gene encoding the protein and gene
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
HUP0104254A2 (hu) Ezrin szabályozó/kihajtogató peptidek
DE60134408D1 (de) Für akzessorische hiv proteine kodierende dna impfstoffe
HUP0200162A2 (hu) Haemophilus somnus transzferrin-kötő fehérjék klónozása és expresszálása
FI960839A (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
DE60113535D1 (de) Kompositionen und verwendungen von cgi-69
AU2002229850A1 (en) Polypeptide inducing hiv-neutralising antibodies